What kind of info are we expecting from this presentation next week? I’m assuming it will be similar to the paper they published on coronaviruses, with inhibition percentages and other detailed results. Will it be in journal article form ready for peer review? I wonder if they will have SIs for the other viruses tested? Or will it be more general “yeah we’re testing Brilacidin against other viruses and it’s working well” type stuff?